Advertisement
Research Article

Genomic Signatures Predict Poor Outcome in Undifferentiated Pleomorphic Sarcomas and Leiomyosarcomas

  • Sara Martoreli Silveira,

    Affiliation: Neogene Laboratory, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil

    X
  • Rolando Andre Rios Villacis,

    Affiliation: Neogene Laboratory, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil

    X
  • Fabio Albuquerque Marchi,

    Affiliation: Institute of Mathematics and Statistics, Inter-Institutional Program on Bioinformatics, USP, São Paulo, São Paulo, Brazil

    X
  • Mateus de Camargo Barros Filho,

    Affiliation: Neogene Laboratory, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil

    X
  • Sandra Aparecida Drigo,

    Affiliation: Department of Urology, Faculty of Medicine, UNESP, Botucatu, São Paulo, Brazil

    X
  • Cristovam Scapulatempo Neto,

    Affiliation: Department of Pathology, Barretos Cancer Hospital (Pio XII Foundation), Barretos, São Paulo, Brazil

    X
  • Ademar Lopes,

    Affiliation: Department of Pelvic Surgery, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil

    X
  • Isabela Werneck da Cunha,

    Affiliation: Department of Pathology, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil

    X
  • Silvia Regina Rogatto mail

    silvia.rogatto@cipe.accamargo.org.br

    Affiliations: Neogene Laboratory, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil, Department of Urology, Faculty of Medicine, UNESP, Botucatu, São Paulo, Brazil

    X
  • Published: June 25, 2013
  • DOI: 10.1371/journal.pone.0067643

Reader Comments (0)

Post a new comment on this article